Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Three new board members for Bacterin

This article was originally published in Clinica

Executive Summary

Bioactive coating specialist Bacterin International has appointed three "seasoned financial experts" to its board of directors: Daniel Frank, Gary Simon and Ken Calligar. Mr Frank has 31 years of asset management experience with a focus on the healthcare industry. He has served on several company boards including stent developer Reva Medical and point-of-care testing firm i-STAT. Mr Simon is currently a manager of UVE Partners, an investment fund that he co-founded. Before this, he was senior vice-president of investment banking firm Barington Capital Group. Mr Calligar is the founder and managing partner of investment banking firm Convertible Capital, and was previously a managing director of Jefferies & Co. He has over 25 years' experience in the financial industry. Belgrade, Montana-based Bacterin develops coatings for medical devices, transplants and tissue products.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095077

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel